» Articles » PMID: 29957236

The Role of Nutraceuticals in Statin Intolerant Patients

Abstract

Statins are the most common drugs administered for patients with cardiovascular disease. However, due to statin-associated muscle symptoms, adherence to statin therapy is challenging in clinical practice. Certain nutraceuticals, such as red yeast rice, bergamot, berberine, artichoke, soluble fiber, and plant sterols and stanols alone or in combination with each other, as well as with ezetimibe, might be considered as an alternative or add-on therapy to statins, although there is still insufficient evidence available with respect to long-term safety and effectiveness on cardiovascular disease prevention and treatment. These nutraceuticals could exert significant lipid-lowering activity and might present multiple non-lipid-lowering actions, including improvement of endothelial dysfunction and arterial stiffness, as well as anti-inflammatory and antioxidative properties. The aim of this expert opinion paper is to provide the first attempt at recommendation on the management of statin intolerance through the use of nutraceuticals with particular attention on those with effective low-density lipoprotein cholesterol reduction.

Citing Articles

Beneficial Effects of a Nutraceutical Combination on Lipid Profiles in Children with Moderate and Severe Hypercholesterolemia.

Garoufi A, Papadaki M, Kalogiannis M, Zerva U, Charakida M, Marmarinos A Biomolecules. 2025; 14(12.

PMID: 39766315 PMC: 11674530. DOI: 10.3390/biom14121608.


Extract, a Natural Approach for Cholesterol and Lipid Metabolism Management: A Randomized, Double-Blind Placebo-Controlled Clinical Trial.

Spina A, Amone F, Zaccaria V, Insolia V, Perri A, Lofaro D Foods. 2024; 13(23).

PMID: 39682955 PMC: 11641072. DOI: 10.3390/foods13233883.


Efficacy, side effects, adherence, affordability, and procurement of dietary supplements for treating hypercholesterolemia: a narrative review.

von Kanel-Cordoba I, Wirnitzer K, Weiss K, Nikolaidis P, Devrim-Lanpir A, Hill L J Health Popul Nutr. 2024; 43(1):189.

PMID: 39563466 PMC: 11575005. DOI: 10.1186/s41043-024-00679-0.


Efficacy and Safety of Evolocumab and Alirocumab as PCSK9 Inhibitors in Pediatric Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis.

Xiao G, Gao S, Xie Y, Wang Z, Shu M Medicina (Kaunas). 2024; 60(10).

PMID: 39459433 PMC: 11509226. DOI: 10.3390/medicina60101646.


Real-World Risk and Outcome of Liver Cirrhosis in Patients with Hyperlipidemia Treated with Red Yeast Rice: A Retrospective Cohort Study.

Chang C, Yeh C, Tiong C, Sun M, Lin J, Cherng Y J Multidiscip Healthc. 2024; 17:3727-3738.

PMID: 39100903 PMC: 11297496. DOI: 10.2147/JMDH.S466696.